RBC8

CAS No. 361185-42-4

RBC8( RBC8 | RBC-8 | RBC 8 )

Catalog No. M17494 CAS No. 361185-42-4

RBC8 is a specific GTPases RalA/RalB inhibitor by inhibiting the binding of Ral to its effector RALBP1, no inhibition on the GTPases RhoA and Ras.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 56 In Stock
5MG 100 In Stock
10MG 177 In Stock
25MG 300 In Stock
50MG 447 In Stock
100MG 651 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    RBC8
  • Note
    Research use only, not for human use.
  • Brief Description
    RBC8 is a specific GTPases RalA/RalB inhibitor by inhibiting the binding of Ral to its effector RALBP1, no inhibition on the GTPases RhoA and Ras.
  • Description
    RBC8 is a RalA and RalB GTPase inhibitor (EC50 ~3.5 μM). RBC8 suppresses growth of xenograft tumors in mice. e Ras-like GTPases RalA and RalB are important drivers of tumour growth and metastasis. Chemicals that block Ral function would be valuable as research tools and for cancer therapeutics.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    RBC8 | RBC-8 | RBC 8
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    Integrin
  • Recptor
    GTPases RalA| GTPases RalB
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    361185-42-4
  • Formula Weight
    424.45
  • Molecular Formula
    C25H20N4O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : ≥ 40 mg/mL; 94.24 mM
  • SMILES
    COc1ccc(c(c1)C1C(=C(N)Oc2c1c(c1ccc3ccccc3c1)[nH]n2)C#N)OC
  • Chemical Name
    6-Amino-4-(2,5-dimethoxyphenyl)-1,4-dihydro-3-(2-naphthalenyl)pyrano[2,3-c]pyrazole-5-carbonitrile

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Yan C, et al. Nature. 2014, 515(7527), 443-447.
molnova catalog
related products
  • MK-0429

    MK-0429 is a potent, selective, orally-active nonpeptide αvβ3 integrin inhibitor with IC50 of 0.08 nM in SPAV3 assay.

  • Bersanlimab

    Bersanlimab (BI-505) is a fully human monoclonal antibody targeting Intercellular Adhesion Molecule-1 (ICAM-1), demonstrating anticancer properties and applicable for studying relapsed/refractory multiple myeloma.

  • SC-68448

    SC-68448 (SC68448) is a potent, selective peptidomimetic antagonist of the integrin αvβ3 with IC50 of 1 nM.